303 related articles for article (PubMed ID: 34031030)
21. Global transcriptome analysis and enhancer landscape of human primary T follicular helper and T effector lymphocytes.
Weinstein JS; Lezon-Geyda K; Maksimova Y; Craft S; Zhang Y; Su M; Schulz VP; Craft J; Gallagher PG
Blood; 2014 Dec; 124(25):3719-29. PubMed ID: 25331115
[TBL] [Abstract][Full Text] [Related]
22. Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis.
He H; Suryawanshi H; Morozov P; Gay-Mimbrera J; Del Duca E; Kim HJ; Kameyama N; Estrada Y; Der E; Krueger JG; Ruano J; Tuschl T; Guttman-Yassky E
J Allergy Clin Immunol; 2020 Jun; 145(6):1615-1628. PubMed ID: 32035984
[TBL] [Abstract][Full Text] [Related]
23. Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study.
Iannone F; Matucci-Cerinic M; Falappone PC; Guiducci S; Cinelli M; Distler O; Lapadula G
J Rheumatol; 2005 Oct; 32(10):1893-8. PubMed ID: 16206343
[TBL] [Abstract][Full Text] [Related]
24. Progranulin Overproduction Due to Fli-1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor in Systemic Sclerosis.
Ichimura Y; Asano Y; Akamata K; Noda S; Taniguchi T; Takahashi T; Toyama T; Tada Y; Sugaya M; Sato S; Kadono T
Arthritis Rheumatol; 2015 Dec; 67(12):3245-55. PubMed ID: 26245842
[TBL] [Abstract][Full Text] [Related]
25. T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.
Almeida I; Silva SV; Fonseca AR; Silva I; Vasconcelos C; Lima M
Clin Rev Allergy Immunol; 2015 Dec; 49(3):347-69. PubMed ID: 26445774
[TBL] [Abstract][Full Text] [Related]
26. Single Cell RNA Sequencing Identifies HSPG2 and APLNR as Markers of Endothelial Cell Injury in Systemic Sclerosis Skin.
Apostolidis SA; Stifano G; Tabib T; Rice LM; Morse CM; Kahaleh B; Lafyatis R
Front Immunol; 2018; 9():2191. PubMed ID: 30327649
[No Abstract] [Full Text] [Related]
27. Systemic and cell type-specific gene expression patterns in scleroderma skin.
Whitfield ML; Finlay DR; Murray JI; Troyanskaya OG; Chi JT; Pergamenschikov A; McCalmont TH; Brown PO; Botstein D; Connolly MK
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12319-24. PubMed ID: 14530402
[TBL] [Abstract][Full Text] [Related]
28. Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin.
Mathes AL; Christmann RB; Stifano G; Affandi AJ; Radstake TR; Farina GA; Padilla C; McLaughlin S; Lafyatis R
Ann Rheum Dis; 2014 Oct; 73(10):1864-72. PubMed ID: 23873879
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional insights into pathogenesis of cutaneous systemic sclerosis using pathway driven meta-analysis assisted by machine learning methods.
Xu X; Ramanujam M; Visvanathan S; Assassi S; Liu Z; Li L
PLoS One; 2020; 15(11):e0242863. PubMed ID: 33253326
[TBL] [Abstract][Full Text] [Related]
30. Three Distinct Transcriptional Profiles of Monocytes Associate with Disease Activity in Scleroderma Patients.
Makinde HM; Dunn JLM; Gadhvi G; Carns M; Aren K; Chung AH; Muhammad LN; Song J; Cuda CM; Dominguez S; Pandolfino JE; Dematte D'Amico JE; Budinger GS; Assassi S; Frech TM; Khanna D; Shaeffer A; Perlman H; Hinchcliff M; Winter DR
Arthritis Rheumatol; 2023 Apr; 75(4):595-608. PubMed ID: 36281773
[TBL] [Abstract][Full Text] [Related]
31. Skin and gut imprinted helper T cell subsets exhibit distinct functional phenotypes in central nervous system autoimmunity.
Hiltensperger M; Beltrán E; Kant R; Tyystjärvi S; Lepennetier G; Domínguez Moreno H; Bauer IJ; Grassmann S; Jarosch S; Schober K; Buchholz VR; Kenet S; Gasperi C; Öllinger R; Rad R; Muschaweckh A; Sie C; Aly L; Knier B; Garg G; Afzali AM; Gerdes LA; Kümpfel T; Franzenburg S; Kawakami N; Hemmer B; Busch DH; Misgeld T; Dornmair K; Korn T
Nat Immunol; 2021 Jul; 22(7):880-892. PubMed ID: 34099917
[TBL] [Abstract][Full Text] [Related]
32. Alteration of circulating miRNAs in SSc: miR-30b regulates the expression of PDGF receptor β.
Tanaka S; Suto A; Ikeda K; Sanayama Y; Nakagomi D; Iwamoto T; Suzuki K; Kambe N; Matsue H; Matsumura R; Kashiwakuma D; Iwamoto I; Nakajima H
Rheumatology (Oxford); 2013 Nov; 52(11):1963-72. PubMed ID: 23893664
[TBL] [Abstract][Full Text] [Related]
33. Oligoclonal T cell expansion in the skin of patients with systemic sclerosis.
Sakkas LI; Xu B; Artlett CM; Lu S; Jimenez SA; Platsoucas CD
J Immunol; 2002 Apr; 168(7):3649-59. PubMed ID: 11907131
[TBL] [Abstract][Full Text] [Related]
34. Compendium of skin molecular signatures identifies key pathological features associated with fibrosis in systemic sclerosis.
Moon SJ; Bae JM; Park KS; Tagkopoulos I; Kim KJ
Ann Rheum Dis; 2019 Jun; 78(6):817-825. PubMed ID: 30952646
[TBL] [Abstract][Full Text] [Related]
35. Epigenomics and transcriptomics of systemic sclerosis CD4+ T cells reveal long-range dysregulation of key inflammatory pathways mediated by disease-associated susceptibility loci.
Li T; Ortiz-Fernández L; Andrés-León E; Ciudad L; Javierre BM; López-Isac E; Guillén-Del-Castillo A; Simeón-Aznar CP; Ballestar E; Martin J
Genome Med; 2020 Sep; 12(1):81. PubMed ID: 32977850
[TBL] [Abstract][Full Text] [Related]
36. Lipoic acid plays a role in scleroderma: insights obtained from scleroderma dermal fibroblasts.
Tsou PS; Balogh B; Pinney AJ; Zakhem G; Lozier A; Amin MA; Stinson WA; Schiopu E; Khanna D; Fox DA; Koch AE
Arthritis Res Ther; 2014; 16(5):411. PubMed ID: 25123250
[TBL] [Abstract][Full Text] [Related]
37. Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis.
Parel Y; Aurrand-Lions M; Scheja A; Dayer JM; Roosnek E; Chizzolini C
Arthritis Rheum; 2007 Oct; 56(10):3459-67. PubMed ID: 17907151
[TBL] [Abstract][Full Text] [Related]
38. Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis.
Cipriani P; Fulminis A; Pingiotti E; Marrelli A; Liakouli V; Perricone R; Pignone A; Matucci-Cerinic M; Giacomelli R
J Rheumatol; 2006 Oct; 33(10):2003-14. PubMed ID: 17014016
[TBL] [Abstract][Full Text] [Related]
39. Dysregulation of the gene signature of effector regulatory T cells in the early phase of systemic sclerosis.
Kobayashi S; Nagafuchi Y; Okubo M; Sugimori Y; Hatano H; Yamada S; Nakano M; Yoshida R; Takeshima Y; Ota M; Tsuchida Y; Iwasaki Y; Setoguchi K; Kubo K; Okamura T; Yamamoto K; Shoda H; Fujio K
Rheumatology (Oxford); 2022 Oct; 61(10):4163-4174. PubMed ID: 35040949
[TBL] [Abstract][Full Text] [Related]
40. T cell repertoire in patients with stable scleroderma.
Tiev KP; Abriol J; Burland MC; Antonelli D; Klatzmann D; Cabane J; Boyer O
Clin Exp Immunol; 2005 Feb; 139(2):348-54. PubMed ID: 15654834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
